This theory was supported by the in vivo treatment of MRT with a small-molecule inhibitor of Gli, which led to the decrease of Gli1 levels and inhibition of tumor growth, whereas Smo inhibitors had no effect (Jagani et al. 2010) (see Table 1). Here, GLI1 is linked to neoplasm.